Drug Trial Radar · NCT05254366
A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,022
Actual
Start
Jan 30, 2022
Primary completion
Feb 8, 2023
Study completion Feb 8, 2023
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 24, 2022
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 2000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained
Conditions
- Gastroscopic and Colonoscopic Sedation
Interventions
Remimazolam Tosilate for InjectionDrug
Remimazolam Tosilate for Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Within 3 days of receiving gastroscopy and colonoscopy
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
The People's Hospital of Chizhou
Chizhou, Anhui, China
First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Shengli Oilfield Central Hospital
Dongying, Guangxi, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Hunan Provincial People's Hospital and The First Affiliated Hospital of Hunan Normal University
Changsha, Hunan, China
Changshu No.2 People's Hospital (Affiliated Changshu Hospital of Nantong University)
Changshu, Jiangsu, China
Suqian People's Hospital of Nanjing Drum Tower Hospital Group
Suqian, Jiangsu, China
Zhangjiagang First People's Hospital
Suzhou, Jiangsu, China
Binzhou Medical University Hospital
Binzhou, Shandong, China
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China
Linyi People's Hospital
Linyi, Shandong, China
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Dazhou Central Hospital
Dazhou, Sichaun, China
Leshan People's Hospital
Leshan, Sichuan, China
Tianjin Nankai Hospital, Tianjin Medical University
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.